20 May 2021 by admin in UncategorizedComments Crescendo Biologics announces initiation of Phase 1 study of CB307 in patients with advanced, PSMA-positive solid tumours
19 May 2021 by admin in UncategorizedComments NextCure to Present Trials in Progress Poster for NC410 at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
19 May 2021 by admin in UncategorizedComments Arcellx to Present Data from Phase 1 Study of CART-ddBCMA Demonstrating Continued Positive Response in Patients with Relapsed and Refractory Multiple Myeloma at the 2021 ASCO Annual Meeting
17 May 2021 by admin in UncategorizedComments Adicet Reports First Quarter 2021 Financial Results and Provides Business Updates
13 May 2021 by admin in UncategorizedComments Preclinical Data of Arcellx’s Novel Synthetic CAR-T Binding Domain Presented at the 2021 ASGCT Annual Meeting and the 2021 PEGS Summit
12 May 2021 by admin in UncategorizedComments Citrine Medicine Announces Strategic Partnership to bring Efmody® to China for Use in Adrenal Insufficiency (AI), including Congenital Adrenal Hyperplasia (CAH)
10 May 2021 by admin in UncategorizedComments Design Therapeutics Announces Business Highlights and Reports First Quarter 2021 Financial Results
10 May 2021 by admin in UncategorizedComments Crescendo Biologics further strengthens leadership team with appointment of Dr Michael Booth as Chief Financial Officer
08 May 2021 by admin in UncategorizedComments Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases
06 May 2021 by admin in UncategorizedComments Syros Reports First Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
